Astronics (ATRO) Form 4: Bought 1,280 Shares at $16.60
Mark Peabody, Executive Vice President & President-Aerospace of Astronics Corp. (ATRO), reported an acquisition of 1,280 common shares on 09/30/2025 via the Employee Stock Purchase Plan at a reported price of $16.60.
Rhea-AI Filing Summary
Mark Peabody, Executive Vice President & President-Aerospace of Astronics Corp. (ATRO), reported an acquisition of 1,280 common shares on 09/30/2025 via the Employee Stock Purchase Plan at a reported price of $16.60. After the transaction the filing shows beneficial ownership figures including 50,824.73 (reported in the form) and 183,994 Class B shares.
The filing lists a portfolio of outstanding long-term equity awards: multiple stock options exercisable through 2033 and several restricted stock unit awards that vest based on Astronics’ average annual adjusted EBITDA over specified multi-year performance periods (2023–2025, 2024–2026, 2025–2027) with stated vesting ranges. The Form 4 was signed by a Power of Attorney on 08/28/2025.
Positive
- Acquisition of 1,280 shares via the Employee Stock Purchase Plan on 09/30/2025 at $16.60
- Performance-based restricted stock units tied to average annual adjusted EBITDA with defined vesting ranges (e.g., 50%–150%, 75%–115%)
Negative
- None.
Insights
TL;DR: Insider purchased 1,280 shares and holds performance-based RSUs tied to adjusted EBITDA.
This Form 4 shows an ESPP purchase of 1,280 shares on 09/30/2025 at $16.60, indicating routine insider participation in a company share-purchase program. The transaction is explicitly recorded and increases reported beneficial ownership.
The filing details multiple long-dated options and restricted stock units whose vesting depends on Astronics’ average annual adjusted EBITDA for defined periods with explicit vesting ranges (for example, 50%–150% or 75%–115%). This ties executive compensation outcomes to disclosed performance metrics without additional conditions in the Form.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | $.01 PV Com Stk | 1,280 | $16.60 | $21K |
| holding | Option | -- | -- | -- |
| holding | Option | -- | -- | -- |
| holding | Option | -- | -- | -- |
| holding | Option | -- | -- | -- |
| holding | Option | -- | -- | -- |
| holding | Option | -- | -- | -- |
| holding | Option | -- | -- | -- |
| holding | Option | -- | -- | -- |
| holding | Option | -- | -- | -- |
| holding | Option | -- | -- | -- |
| holding | Option | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | Option | -- | -- | -- |
| holding | Restricted Stock Unit | -- | -- | -- |
| holding | $.01 PV CL B STK | -- | -- | -- |
Footnotes (5)
- F1. Acquired shares via exercise of subscription agreement under Employee Stock Purchase Plan.
- F2. Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- F3. Vesting of these restricted stock units depends on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2024- December 31, 2026. The "target" number of restricted stock units is reported. Between 50% and 150% of the target number of units may vest on February 22, 2027, with the vesting percentage determined based on actual performance.
- F4. Vesting of these restricted stock units depends on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2023- December 31, 2025. The "target" number of restricted stock units is reported. Between 75% and 115% of the target number of units may vest on February 23, 2026, with the vesting percentage determined based on actual performance.
- F5. Vesting of these restricted stock units depends on Astronics Corp.'s average annual adjusted EBITDA for the period January 1, 2025- December 31, 2027. The "target" number of restricted stock units is reported. Between 50% and 150% of the target number of units may vest on February 27, 2028, with the vesting percentage determined based on actual performance.
FAQ
What did Mark Peabody report on the Form 4 for ATRO?
Are there outstanding options and RSUs disclosed for the reporting person?
What performance metric controls RSU vesting in this filing?
Who signed the Form 4 on behalf of the reporting person?
AI-generated analysis. How Rhea-AI works. Not financial advice.
